Aberrant expression and possible involvement of the leptin receptor in endometrial cancer.
about
Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancerMolecular cues on obesity signals, tumor markers and endometrial cancer.Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation.Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells.Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways.Obesity, adipocytokines and cancerPotential role of leptin expression in hepatocellular carcinoma.Effects of dietary high fat on prostate intraepithelial neoplasia in TRAMP miceSerum leptin, adiponectin and endometrial cancer risk in Chinese women.Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer.Leptin receptor expression during the progression of endometrial carcinoma is correlated with estrogen and progesterone receptors.Expression of leptin receptor in endometrial biopsies of endometrial and ovarian cancer patients.Leptin expression in proliferative, secretory and hyperplastic endometrial tissues.Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer.Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.Reduction of aflatoxin level in aflatoxin-induced rats by the activity of probiotic Lactobacillus casei strain Shirota.Prolactin promotes hepatocellular carcinoma through Janus kinase 2.
P2860
Q26750563-27C15F00-9371-44B7-AE27-EFAC58F12D30Q30372789-DD0A18C4-3973-4DFF-8ADA-ED5F1951829EQ33665375-102CB485-783A-4438-A5C5-B67F00DA6CD4Q33808855-183D3EA1-AC11-487D-AC11-F7524A934D16Q33941240-C01E5AA8-4A79-47BD-B760-998E479334A5Q34078555-8273C068-BCB4-4B65-9F5F-754817B0A9A2Q34497726-84A07E8E-3591-441E-9030-BAF4CAFC9239Q35770282-26CC00EA-F507-40F0-993E-1B88ADAE8342Q36739349-41DEFB4F-07E0-4A1A-A767-72E40C778784Q37249298-AE14EF46-34A3-493C-A100-B78749AD0585Q37277170-543BFBC9-49A0-4A4F-BC2D-AA1CA034307CQ37549414-65E25550-7538-4C94-A7A6-395D62EFF6A2Q37566675-6F19718D-E98B-418F-8B37-38FFF44ED1CDQ37611375-913D9029-36AA-480B-9E4E-C2D5AB26D225Q38303122-26C15EC4-62C3-4AB3-917C-4723D1956420Q38334344-2F9B9206-4038-4213-9AF1-AC75B9295A54Q39478860-3B5EE78C-599D-43BC-B35A-7A33411F4CEFQ54525376-38172B6C-4F7B-4ABC-9C75-DF5D92E26EF0
P2860
Aberrant expression and possible involvement of the leptin receptor in endometrial cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Aberrant expression and possib ...... eceptor in endometrial cancer.
@en
type
label
Aberrant expression and possib ...... eceptor in endometrial cancer.
@en
prefLabel
Aberrant expression and possib ...... eceptor in endometrial cancer.
@en
P2093
P1433
P1476
Aberrant expression and possib ...... eceptor in endometrial cancer.
@en
P2093
Jinu-Huang Su
Kun-Bow Tsai
Li-Yu Tsai
Shyng-Shiou F Yuan
Te-Fu Chan
Yao-Tsung Yeh
Yueh-Fang Chung
P304
P356
10.1016/J.YGYNO.2003.11.043
P407
P577
2004-03-01T00:00:00Z